We can't find the internet
Attempting to reconnect
44222.1 IP-LS
44222.1 IP-LS
Résumé
Epigenetic regulation to improve imaging and therapy of neuroendocrine tumours with ST8950 a new SSTR2/SSTR5 agonist
Textes supplémentaires
Abstract
A new Somatostatine analog (SSA) ST8950, will be used on Pharmacologicaly-upregulated somatostatine receptors (SSTR2 and SSTR5) in vitro and in mice model. ST8950 exhibits a better balanced affinity toward SSTR2 and SSTR5 than the current SSA marketed and will improve theranostic strategy.
Participants
Alan Harris
Wirtschaftspartner
SomTheranostics Sàrl Alan Harris Chemin de Beaufort 12 1162 St-Prex VD CH
Karim Abid
Kontaktperson
karim-alexandre.abid@chuv.ch
CHUV Centre Hospitalier Universitaire Va Karim Abid Avenue Pierre Decker 5 1011 Lausanne VD CH
Détails du projet
- Office de recherche
- INNOSUISSE
- Statut du projet
- In Bearbeitung
- Type de projet
- Forschungsprojekt
- Date de début
- 2021-06-30
- Date de fin
- 2023-06-30
- Coûts totaux approuvés
- CHF 395472.00
- Section
- 60 Life Sciences
- Domaine politique NABS
- Industrielle Produktivität und Technologie
Disciplines de recherche
- T410 Pharmaceuticals and related technologies 100.0%